Celldex Therapeutics, Inc. (NASDAQ:CLDX) reported business and financial highlights for the fourth quarter and year ended December 31, 2013 and outlined the Company’s major clinical development goals for 2014. Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares after opening at $18.62 moved to $18.97 on last trade day and at the end of the day closed at $16.95. Company price to sales ratio in past twelve months was calculated as 193.41 and price to cash ratio as 10.05. Celldex Therapeutics, Inc. (NASDAQ:CLDX) showed a negative weekly performance of -21.24%.
Unilife Corporation (NASDAQ:UNIS) announced that Mr. Dennis Pyers, Vice-President and Controller of Unilife since 2010, has been named Interim CFO. Mr. Pyers replaces Mr. Richard Wieland who is leaving Unilife after four years as Executive Vice President and Chief Financial Officer. Unilife Corp (NASDAQ:UNIS) shares fell -8.08% in last trading session and ended the day on $3.98. UNIS return on equity ratio is recorded as % and its return on assets is -179.90%. Unilife Corp (NASDAQ:UNIS) yearly performance is 82.57%.
Inovio Pharmaceuticals, Inc (NYSEMKT:INO)was a big mover last session, as the company saw its shares shoot up nearly 13% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. Inovio Pharmaceuticals Inc (NYSEMKT:INO) shares moved down -9.89% in last trading session and was closed at $3.28 while trading in range of $3.15 -$3.64 – Inovio Pharmaceuticals Inc (NYSEMKT:INO) year to date (YTD) performance is 13.10%.
Investment analysts at Mizuho lifted their target price on shares of EXACT Sciences (NASDAQ:EXAS) from $18.00 to $22.00 in a note issued to investors on Friday, AnalystRatingsNetwork.com reports. Mizuho’s price target suggests a potential upside of 60.00% from the company’s current price. EXACT Sciences Corporation (NASDAQ:EXAS) weekly performance is -11.19%. On last trading day company shares ended up $12.86. EXACT Sciences Corporation (NASDAQ:EXAS) distance from 50-day simple moving average (SMA50) is -5.10%. Analysts mean target price for the company is $17.33.
Leave a Reply